Works by Shimazu, Kenzo

Results: 73
    1
    2

    Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)].

    Published in:
    Oncology, 2010, v. 78, n. 5/6, p. 302, doi. 10.1159/000318169
    By:
    • Taguchi, Tetsuya;
    • Masuda, Norikazu;
    • Nakayama, Takahiro;
    • Motomura, Kazuyoshi;
    • Tsukamoto, Fumine;
    • Shimazu, Kenzo;
    • Nomura, Takashi;
    • Morimoto, Takashi;
    • Yamamoto, Hiroshi;
    • Wakita, Kazuyuki;
    • Nakano, Yoshiaki;
    • Yoneda, Kohri;
    • Inaji, Hideo;
    • Takatsuka, Yuichi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    3
    4
    5
    6
    7

    WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1.

    Published in:
    Cancers, 2023, v. 15, n. 2, p. 393, doi. 10.3390/cancers15020393
    By:
    • Oji, Yusuke;
    • Kagawa, Naoki;
    • Arita, Hideyuki;
    • Naka, Norifumi;
    • Hamada, Ken-ichiro;
    • Outani, Hidetatsu;
    • Shintani, Yasushi;
    • Takeda, Yoshito;
    • Morii, Eiichi;
    • Shimazu, Kenzo;
    • Suzuki, Motoyuki;
    • Nishida, Sumiyuki;
    • Nakata, Jun;
    • Tsuboi, Akihiro;
    • Iwai, Miki;
    • Hayashi, Sae;
    • Imanishi, Rin;
    • Ikejima, Sayaka;
    • Kanegae, Mizuki;
    • Iwamoto, Masahiro
    Publication type:
    Article
    8
    9

    Preclinical evaluation of <sup>64</sup>Cu-labeled cetuximab in immuno-PET for detecting sentinel lymph node metastasis in epidermal growth factor receptor-positive breast cancer.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01972-4
    By:
    • Usui, Takeshi;
    • Miyake, Tomohiro;
    • Watabe, Tadashi;
    • Kato, Hiroki;
    • Yoshii, Yukie;
    • Naka, Sadahiro;
    • Abe, Kaori;
    • Masuyama, Misato;
    • Masunaga, Nanae;
    • Yoshinami, Tetsuhiro;
    • Tsukabe, Masami;
    • Sota, Yoshiaki;
    • Tanei, Tomonori;
    • Shimoda, Masafumi;
    • Shimazu, Kenzo
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest<sup>™</sup> 95GC Breast in a multi‑institutional registry study.

    Published in:
    Oncology Letters, 2023, v. 25, n. 5, p. N.PAG, doi. 10.3892/ol.2023.13794
    By:
    • Naoi, Yasuto;
    • Tsunashima, Ryo;
    • Shimazu, Kenzo;
    • Oikawa, Masahiro;
    • Imanishi, Seiichi;
    • Koyama, Hiroshi;
    • Kamada, Yoshihiko;
    • Ishihara, Kazuhiro;
    • Suzuki, Masahiko;
    • Osako, Tomo;
    • Kinoshita, Takayuki;
    • Suto, Akihiko;
    • Nakamura, Seigo;
    • Tsuda, Hitoshi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    24
    25
    26

    A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large‐scale, multicenter cohort study.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 10, p. 1913, doi. 10.1002/cncr.34144
    By:
    • Osako, Tomo;
    • Matsuura, Masaaki;
    • Yotsumoto, Daisuke;
    • Takayama, Shin;
    • Kaneko, Koji;
    • Takahashi, Mina;
    • Shimazu, Kenzo;
    • Yoshidome, Katsuhide;
    • Kuraoka, Kazuya;
    • Itakura, Masayuki;
    • Tani, Mayumi;
    • Ishikawa, Takashi;
    • Ohi, Yasuyo;
    • Kinoshita, Takayuki;
    • Sato, Nobuaki;
    • Tsujimoto, Masahiko;
    • Nakamura, Seigo;
    • Tsuda, Hitoshi;
    • Noguchi, Shinzaburo;
    • Akiyama, Futoshi
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 9, p. 2603, doi. 10.1245/s10434-018-6633-0
    By:
    • Kenzo Shimazu;
    • Nobuaki Sato;
    • Akiko Ogiya;
    • Yoshiaki Sota;
    • Daisuke Yotsumoto;
    • Takashi Ishikawa;
    • Seigo Nakamura;
    • Takayuki Kinoshita;
    • Hitoshi Tsuda;
    • Yasuyo Ohi;
    • Futoshi Akiyama;
    • Shinzaburo Noguchi
    Publication type:
    Article
    40
    41

    Evaluation of Targeted Alpha Therapy Using [ 211 At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 21, p. 11567, doi. 10.3390/ijms252111567
    By:
    • Abe, Kaori;
    • Watabe, Tadashi;
    • Kaneda-Nakashima, Kazuko;
    • Shirakami, Yoshifumi;
    • Kadonaga, Yuichiro;
    • Naka, Sadahiro;
    • Ooe, Kazuhiro;
    • Toyoshima, Atsushi;
    • Giesel, Frederik;
    • Usui, Takeshi;
    • Masunaga, Nanae;
    • Mishima, Chieko;
    • Tsukabe, Masami;
    • Yoshinami, Tetsuhiro;
    • Sota, Yoshiaki;
    • Miyake, Tomohiro;
    • Tanei, Tomonori;
    • Shimoda, Masafumi;
    • Shimazu, Kenzo
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Initial Evaluation of [<sup>18</sup>F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1225, doi. 10.2967/jnumed.123.265486
    By:
    • Tadashi Watabe;
    • Sadahiro Naka;
    • Mitsuaki Tatsumi;
    • Takashi Kamiya;
    • Toru Kimura;
    • Yasushi Shintani;
    • Kaori Abe;
    • Tomohiro Miyake;
    • Kenzo Shimazu;
    • Shogo Kobayashi;
    • Yukinori Kurokawa;
    • Hidetoshi Eguchi;
    • Yuichiro Doki;
    • Hidenori Inohara;
    • Hiroki Kato;
    • Yuriko Mori;
    • Cardinale, Jens;
    • Giesel, Frederik L.
    Publication type:
    Article
    49
    50